Intense Research for Effective Therapy

Throughout the world, more and more people are being diagnosed with diabetes. Projections are assuming that by 2030, considerably more than 400 million people will suffer from this metabolic disease. The causes of diabetes mellitus are mainly being overweight, following a sedentary lifestyle, and eating the wrong food. They lead from insulin resistance to the lack of insulin and a higher blood sugar level. 

Research done by Wörwag Pharma concentrates on the consequences of the disease, such as diabetic nerve damage. The aim is to encourage findings in the field of vitamins, minerals, and trace elements.

Company founder Dr. Fritz Wörwag has developed the active ingredient benfotiamine further and it became a milestone in the therapy of diabetic comorbidities. With its high bioavailability, it significantly contributes to protect against vitamin B1 deficiency.  

International clinical studies, meetings of experts, and symposia, plus close collaboration with research labs: We invest in science and clinical research so we can develop the best possible medications for our patients.

The Fritz Wörwag Research Prize

The Fritz Wörwag Research Prize honours scientists and researchers working on the clinical application of biofactors, for example the treatment of diabetes or the thiamine metabolism.

xx xx
Prof. Dan Ziegler
Institute of Clinical Diabetology at the German Diabetes Centre, Heinrich Heine University Düsseldorf
2013Dr. Alin Stirban
Profile Institute for Metabolic Research, Neuss
Prof. Dr. Paul Thornalley
University of Warwick, U.K.
1999Prof. Dr. med. Hans-Peter Hammes
Mannheim Medical Center
1996Prof. Dr. med. Hilmar Stracke
Med. Clinic and Polyclinic of the University of Giessen
1994Prof. Dr. Hans Konrad Biesalski
University of Hohenheim
1991Prof. Dr. Roland Bitsch
Nutritional Sciences Institute of the University of Jena
1988Prof. Dr. Klaus-Henning Krause
Friedrich Bauer Institute, Munich
20182. Preis: Prof. Jacqueline A. Pettersen
University of Northern British Columbia, Prince George (Kanada)
Junior Researcher Prize: Ms. Chune Liu
University of Freiburg Medical Center
2009Prof. Dr. med. Vedat Schwenger
University of Heidelberg Medical Center
2007Junior Researcher Prize: Dr. Nicole Schupp
Pharmacology and Toxicology Institute, Würzburg
Prof. Dr. Walter Zidek
Polyclinic of the University of Münster

Prizes are awarded for work – including well-founded reviews – that make a significant scientific contribution and contain new experimental or clinical findings on the topic of "Biofactors for Neuroprotection". The prize is awarded on the basis of the decision of an independent jury. The objective of the science prize, which was established by the company founder Dr. Fritz Wörwag, is to support and promote researchers in the field of the clinical application of biofactors.